Study details
Enrolling now
Hyperpolarized Imaging to Help Diagnose Glioma
Susan Chang
NCT IDNCT03739411ClinicalTrials.gov data as of Apr 2026
Phase
Phase 1
Target enrollment
140
Study length
about 12 years
Ages
19+
Locations
1 site in CA
What this study is about
This trial is testing a new imaging technique called hyperpolarized carbon C 13 pyruvate MRI in adults with glioma. The goal is to see if this imaging method can help doctors find and diagnose gliomas.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Receive Hyperpolarized Carbon C 13 Pyruvate
- 2.Receive Radiation Therapy
- 3.Take Chemotherapy
- +1 more
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Endpoints
Primary: Incidence of adverse events
Procedures
imaging, radiation